A PRP preparation device and preparation method

By using uncharged single-layer polyester fiber nonwoven filter membrane and sterile protective cover structure in the PRP preparation device, the problems of long preparation time, high risk of contamination and incomplete leukocyte filtration in the prior art are solved, and the problems of incomplete leukocyte filtration in the prior art are achieved. Faster and purer PRP preparation, reduce the concentration of inflammatory factors and improve the therapeutic effect.

CN111495614BActive Publication Date: 2024-11-05WEST CHINA HOSPITAL SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010349553.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-04-28
Publication Date
2024-11-05
Estimated Expiration
2040-04-28

AI Technical Summary

Technical Problem

The existing PRP preparation methods have problems such as long preparation time, high risk of pollution, high blood waste and incomplete leukocyte filtration, especially during treatments such as osteoarthritis and cartilage regeneration, which may cause early joint swelling, aggravation of pain and decreased later efficacy. .

Method used

A PRP preparation device was designed, using an uncharged single-layer polyester fiber non-woven filter membrane, with a filter pore size between 2μm and 7μm, which can effectively block white blood cells and red blood cells, reduce blood waste and increase PRP concentration. Combining the sterile protective cover and collection funnel structure simplifies the operation process.

Benefits of technology

Faster and purer PRP preparation is achieved, reducing the total blood draw and contamination risk of patients, reducing the concentration of inflammatory factors, and improving the therapeutic effect and efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111495614B_ABST
    Figure CN111495614B_ABST
Patent Text Reader

Abstract

The present invention provides a PRP preparation device and a preparation method, which relates to the technical field of PRP preparation, and solves the problems of long PRP preparation time, high contamination risk and large total blood draw of patients in the prior art. The preparation device includes a filter membrane with a sterile protective cover arranged therein, the sterile protective cover has a blood collection tube connection port and a centrifuge tube connection port, the circumference of the filter membrane is connected to the inner wall of the sterile protective cover, the filter membrane is located between the blood collection tube connection port and the centrifuge tube connection port, the filter membrane includes at least one layer of uncharged single-layer polyester fiber non-woven fabric, and the filter pore size of the filter membrane is less than or equal to 7μm. The preparation method uses a blood collection tube, a centrifuge tube, a centrifuge and the preparation device to prepare PRP. The present invention can obtain high-concentration PRP more quickly, reduce contamination risk and preparation time, reduce the total blood draw of patients, reduce blood waste, and solve the problem of filtering out red blood cells while avoiding red blood cells covering the filter membrane.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of PRP preparation, in particular to a PRP preparation device and a PRP preparation method. Background Art

[0002] PRP (Platelet-rich plasm) is a plasma component containing a large number of platelets obtained by centrifuging and extracting autologous blood. The platelets contained in it are significantly higher than those in normal human plasma.

[0003] Platelets are very small blood cells with a diameter of less than 2μm, usually invisible to the naked eye. The content of platelets in normal human blood is at least 100,000 to 150,000 platelets per 1μl. PRP can be divided into many types according to the content of white blood cells and fibrin, such as leukocyte-depleted PRP, leukocyte-rich PRP, defibrinated PRP and platelet-rich fibrin PRP. PRP contains a lot of growth factors (GFs), which are mainly produced by α-granules released by activated platelets, such as vascular endothelial growth factor, platelet-derived growth factor, transforming growth factor-β3, etc. These factors have beneficial effects on wound healing and tissue repair. In addition, the growth factors contained in PRP, such as insulin-like growth factor (IGF), transforming growth factor β and fibroblast growth factor, can promote the expression of Col-II and protease in mesenchymal stem cells, promote chondrocyte proliferation, regulate the ability of mesenchymal stem cells to differentiate and the synthesis of extracellular matrix, and then participate in the repair of tissue damage, articular cartilage defects, bone defects and wound healing.

[0004] According to the concentration of white blood cells, PRP can be divided into two categories: leukocyte-rich PRP containing high concentrations of white blood cells and leukocyte-depleted PRP containing no or only low concentrations of white blood cells. Leukocytes are colorless, spherical, nucleated blood cells. They are not a uniform cell group. According to their morphology, function and source, they can be divided into three categories: granulocytes, monocytes and lymphocytes. Among them, granulocytes can be divided into neutrophils, eosinophils and basophils according to the different staining properties of granules in the cytoplasm. The diameter of white blood cells is 5-25μm, among which the diameter of monocytes is 14-25μm, the diameter of large lymphocytes is 13-20μm, the diameter of medium lymphocytes is 9-12μm, the diameter of small lymphocytes is 5-8μm, the diameter of eosinophils is 10-15μm, the diameter of neutrophils is 10-12μm, and the diameter of basophils is 10-12μm, which are much larger than 2μm.

[0005] M2 macrophages can be recruited locally in damaged skeletal muscle, inhibit scar formation, and promote the repair and regeneration of skeletal muscle tissue. However, M2 macrophages in damaged tissues do not exist directly in whole blood, but are mainly derived from monocytes that are chemotactic and activated in situ by the local inflammatory environment. Therefore, it is impossible for M2 macrophages that have a certain beneficial effect on tissue repair to exist in leukocyte-rich PRP. Leukocyte subtypes such as lymphocytes can directly or indirectly participate in tissue remodeling by secreting bioactive factors, but these effects may not be necessary for tissue repair. Leukocyte subtypes such as granulocytes and monocytes may inhibit tissue repair by secreting inflammatory factors. The concentrations of IL-1β (interleukin-1β) and TNF-α (tumor necrosis factor-α) in leukocyte-rich PRP are significantly higher than those in leukocyte-depleted PRP, resulting in the fact that the promoting effect of leukocyte-rich PRP on the proliferation and migration of chondrocytes is significantly inferior to that of leukocyte-depleted PRP.

[0006] Therefore, it is feasible to obtain a higher concentration of leukocyte-poor platelets by directly filtering the blood.

[0007] At present, the preparation of platelet-rich plasma (PRP) relies on centrifuges. Centrifugation methods can be divided into two categories: single centrifugation and double centrifugation, the latter of which is the most commonly used. Double centrifugation generally first undergoes relatively low-speed centrifugation (speed 100×g, centrifugation for 10 minutes) to separate plasma and platelets from red blood cells and white blood cells, and then undergoes relatively high-speed centrifugation (centrifugal force 400×g, centrifugation for 10 minutes) to further concentrate PRP and separate platelet-poor plasma components to obtain the best platelet concentration. The two centrifugation speeds used by Marx et al. were 5600rpm and 2400rpm, respectively, and the average platelet concentration was 3.3g / L. Perez et al. centrifuged at 723rpm for 10 minutes for the first time and at 1445rpm for 10 minutes for the second time, and the platelet concentration was 3 times higher than the basal concentration. In order to obtain a platelet concentration of 1.6 to 4.9 times the baseline value and reduce the risk of PRP contamination and platelet loss by reducing the amount of specimen manipulation, Gómez LA et al. recommended a single centrifugation at 1500 rpm for 10 minutes. In order to ensure the effective concentration, the secondary centrifugation method is mainly used, but it takes a lot of time to wait for preparation. At the same time, the risk of infection in secondary centrifugation is relatively high. In the separation process, in order to collect as many platelets as possible, a large number of white blood cells will be collected at the same time. For some diseases and repairs, such as osteoarthritis, cartilage regeneration and bone regeneration, it can cause early joint swelling and increased pain after injection, and decreased efficacy in the later stage.

[0008] Therefore, alleviating the effects of inflammation represented by white blood cells, IL-1β and TNF-α is a key factor in improving efficacy. Summary of the invention

[0009] The purpose of the present invention is to design a PRP preparation device and preparation method, which can obtain high-concentration PRP more quickly, reduce the risk of contamination and preparation time, reduce the total amount of blood drawn from patients, reduce blood waste and solve the problem of filtering out red blood cells while avoiding red blood cells covering the filter membrane.

[0010] The present invention is achieved through the following technical solutions:

[0011] The present invention provides a PRP preparation device, comprising a sterile protective cover and a filter membrane;

[0012] The inner side of the sterile protective cover forms a storage space, and the sterile protective cover is provided with a blood collection tube connection port and a centrifuge tube connection port which are communicated with the storage space, the blood collection tube connection port is used to connect the blood collection tube, and the centrifuge tube connection port is used to connect the centrifuge tube;

[0013] The filter membrane is arranged in the accommodation space of the sterile protective cover, the circumference of the filter membrane is connected to the inner wall of the sterile protective cover, the filter membrane is located between the blood collection tube connection port and the centrifuge tube connection port, the filter membrane includes at least one layer of uncharged single-layer polyester fiber non-woven fabric, and the filter pore size of the filter membrane is greater than or equal to 2 μm and less than or equal to 7 μm;

[0014] The blood from the blood collection tube connection port can flow through the centrifuge tube connection port after being filtered by the filter membrane.

[0015] When the above-mentioned structure is used, the filter membrane is a non-charged polyester fiber non-woven fabric, which will not act on the charged growth factors and reduce the filtration amount of the growth factors. The filter membrane with a filtration pore size of less than 7μm can block most white blood cells while blocking red blood cells, which can greatly reduce the number of white blood cells and red blood cells in the filtrate, and can obtain purer PPP (platelet-deficient plasma) and platelets. It can reduce the total amount of blood drawn from patients to reduce the generation of blood waste and effectively solve the problem of red blood cells covering the filter membrane and clogging the filter membrane. When the filtrate is centrifuged, a high concentration of PRP can be obtained more quickly, reducing the risk of contamination and preparation time. The prepared PRP can reduce the concentration of inflammatory factors represented by white blood cells, IL-1β and TNF-α, and improve the regeneration and repair effect of PRP.

[0016] In order to better realize the present invention, the following configuration is particularly adopted: the filtration pore size of the filtration membrane is greater than or equal to 2 μm and less than or equal to 5 μm.

[0017] When the above-mentioned setting structure is adopted, the filtration pore size of the filter membrane is below 5μm, which can further filter out white blood cells including small lymphocytes, and can further increase the concentration of PPP (platelet-deficient plasma) and platelets in the filtrate, which is more conducive to the rapid preparation of high-concentration PRP.

[0018] In order to further better realize the present invention, the following configuration structure is particularly adopted: the blood collection tube connection port and the centrifuge tube connection port of the sterile protective cover are installed with sterile caps.

[0019] When the above-mentioned configuration structure is adopted, the configuration of the sterile cap can effectively prevent the accommodating space of the sterile protective cover and the filter membrane in the accommodating space from being contaminated.

[0020] In order to better realize the present invention, the following setting structure is particularly adopted: the PRP preparation device also includes a collecting funnel, the centrifuge tube connecting port of the sterile protective cover is sealed and connected to the collecting funnel, the centrifuge tube connecting port is connected to the discharge end of the collecting funnel, the discharge end of the collecting funnel is installed with a sterile cap, and the discharge end of the collecting funnel is used to connect the centrifuge tube.

[0021] When the above-mentioned structure is adopted, the collecting funnel is conducive to collecting the filtrate, which can speed up the collection of the filtrate.

[0022] In order to better realize the present invention, the following configuration is particularly adopted: the diameter of the filtration membrane is 1-6 cm.

[0023] When the above-mentioned configuration is adopted, a filter membrane with a diameter of 1-6 cm is selected according to different blood collection amounts to ensure higher filtration efficiency and lower filtration cost.

[0024] In order to better realize the present invention, the following configuration structure is particularly adopted: the height of the collecting funnel is 1-2 cm, and the volume of the collecting funnel is 20-30 ml.

[0025] In order to further better realize the present invention, the following setting structure is particularly adopted: the PRP preparation device also includes a blood collection tube and a centrifuge tube, the blood collection tube is detachably connected to the blood collection tube connection port of the sterile protective cover, and the centrifuge tube is detachably connected to the discharge end of the collecting funnel.

[0026] In order to better realize the present invention, the following configuration is particularly adopted: the blood collection tube is an injection needle structure with an injection piston, and the centrifuge tube is an injection needle structure with an injection piston.

[0027] When the above-mentioned configuration structure is adopted, the filtration after blood collection and the centrifugation after the filtrate is obtained can be facilitated, thereby reducing the intermediate operation time and improving the centrifugal efficiency.

[0028] To further better realize the present invention, the following configuration is particularly adopted: the sterile protective cover is a sterile transparent plastic shell or a sterile transparent plastic film.

[0029] When the above-mentioned setting structure is adopted, the filtering effect can be observed conveniently and the processing can be carried out in time.

[0030] The present invention also provides a PRP preparation method, which uses a blood collection tube, a centrifuge tube, a centrifuge and the above-mentioned PRP preparation device to prepare PRP, comprising the following steps:

[0031] S1. Connect the centrifuge tube to the centrifuge tube connection port of the sterile protective cover;

[0032] S2. Collect the patient's own venous blood into a blood collection tube under sterile conditions;

[0033] S3, connecting the blood collection tube after collecting blood to the blood collection tube connection port of the sterile protective cover, and squeezing the blood in the blood collection tube to the filter membrane for filtering to obtain a filtrate;

[0034] S4, introducing the filtrate into a centrifuge tube, removing the seal of the centrifuge tube containing the filtrate and installing it in a centrifuge;

[0035] S5. Set the centrifugal time and centrifugal force and start the centrifuge.

[0036] When the above-mentioned setting is adopted, the PRP preparation device can be relied upon to quickly and as much as possible separate plasma and platelets from the blood, and filter out as many white blood cells and red blood cells as possible, so as to quickly obtain high-concentration PRP, reduce the risk of contamination and preparation time, and also reduce the total amount of blood drawn from the patient and blood waste and solve the problem of red blood cells and the like covering the filter membrane.

[0037] In order to better realize the present invention, the following configuration is particularly adopted: the blood volume in the blood collection tube is controlled at 20-30 ml.

[0038] To further implement the present invention, the following settings are particularly adopted: the centrifugal time of the centrifuge is set at 5-8 min, and the centrifugal force is set at 300-400×g.

[0039] The present invention has the following advantages and beneficial effects:

[0040] In the present invention, the filter membrane is a non-charged polyester fiber non-woven fabric, which will not act on the growth factors with charge and reduce the filtration amount of the growth factors. The filter membrane has a filtration pore size of less than 7 μm, which can block most white blood cells while blocking red blood cells, and can greatly reduce the number of white blood cells and red blood cells in the filtrate, and can obtain purer PPP (platelet-deficient plasma) and platelets, which can reduce the total amount of blood drawn from patients to reduce the generation of blood waste and effectively solve the problem of red blood cells covering the filter membrane and clogging the filter membrane. When the filtrate is centrifuged, a high concentration of PRP can be obtained more quickly, reducing the risk of contamination and preparation time. The prepared PRP can reduce the concentration of inflammatory factors represented by white blood cells, IL-1β and TNF-α, and improve the regeneration and repair effect of PRP. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0042] Figure 1 is a schematic structural diagram of the PRP preparation device in Example 1;

[0043] Figure 2 is a schematic structural diagram of the PRP preparation device in Example 2;

[0044] The markings in the figure are:

[0045] 1. Sterile protective cover; 2. Filter membrane; 3. Blood collection tube connection port; 4. Centrifuge tube connection port; 5. Collection funnel; 6. Blood collection tube; 7. Centrifuge tube. DETAILED DESCRIPTION

[0046] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0047] Embodiment 1:

[0048] A PRP preparation device can obtain high-concentration PRP more quickly, reduce the risk of contamination and preparation time, reduce the total amount of blood drawn from patients, reduce blood waste, and solve the problem of filtering out red blood cells while avoiding red blood cells covering the filter membrane, such as Figure 1 , Figure 2 As shown, it is particularly configured as follows:

[0049] Basically, it includes a sterile protective cover 1 and a filter membrane 2.

[0050] The sterile protective cover 1 is roughly a dome cover shell, and a storage space is formed inside the dome cover shell. In this embodiment, in order to facilitate observation of the filtering process, the sterile protective cover 1 is a sterile transparent plastic shell or a sterile transparent plastic film, so that when filtering problems are observed, they can be handled in a timely manner. An extension tube is provided at the top center of the sterile protective cover 1, and the end of the extension tube is a blood collection tube connection port 3 for connecting to a blood collection tube 6. A centrifuge tube connection port 4 for connecting to a centrifuge tube 7 is provided at the bottom center of the sterile protective cover 1. The blood collection tube connection port 3 and the centrifuge tube connection port 4 are both connected to the storage space of the sterile protective cover 1.

[0051] When not in use, sterile caps need to be installed at the blood collection tube connection port 3 and the centrifuge tube connection port 4 of the sterile protective cover 1 to effectively prevent the accommodating space of the sterile protective cover 1 and the filter membrane 2 in the accommodating space from being contaminated.

[0052] A horizontally placed filter membrane 2 is provided in the middle of the storage space of the sterile protective cover 1, and the filter membrane 2 is located between the blood collection tube connection port 3 and the centrifuge tube connection port 4. The circumference of the filter membrane 2 is sealedly connected to the inner wall of the sterile protective cover 1 to divide the storage space into two parts, upper and lower parts, so that the blood from the blood collection tube connection port 3 can be filtered by the filter membrane 2 and then flow through the centrifuge tube connection port 4. The filter membrane 2 can be a single layer of polyester fiber non-woven fabric or two or three layers of single layer of polyester fiber non-woven fabric stacked in sequence. The polyester fiber non-woven fabric is not charged. The filtration pore size of the filter membrane 2 needs to filter as many platelets as possible. Therefore, the effective filtration pore size of the filter membrane 2 should be greater than or equal to 2μm. In order to filter out white blood cells while also filtering out as many red blood cells as possible, the effective filtration pore size of the filter membrane 2 should be less than or equal to 7μm. Preferably, in order to further filter out white blood cells below 7μm and obtain a higher concentration of platelets, the effective filtration pore size of the filter membrane 2 should be less than or equal to 5μm. The filtration pore size of the filter membrane 2 is below 5μm, which can further filter out white blood cells including small lymphocytes, and can further increase the concentration of PPP and platelets in the filtrate, which is more conducive to the rapid preparation of high-concentration PRP.

[0053] The diameter of the filter membrane 2 can be determined according to the amount of filtered blood, that is, the amount of blood collected, and is generally 1-6 cm. According to the amount of blood collected, a filter membrane with a diameter of 1-6 cm is selected to ensure higher filtration efficiency and lower filtration cost.

[0054] The filter membrane 2 is a non-woven polyester fiber fabric without charge, which will not act on the growth factors with charge and reduce the amount of growth factors filtered. The filter pore size of the filter membrane 2 is below 7μm, which can block most white blood cells while blocking red blood cells, and can greatly reduce the number of white blood cells and red blood cells in the filtrate, and can obtain purer PPP (platelet-deficient plasma) and platelets, which can reduce the total amount of blood drawn from patients to reduce the generation of blood waste and effectively solve the problem of red blood cells covering the filter membrane and clogging the filter membrane. When the filtrate is centrifuged, a high concentration of PRP can be obtained more quickly, reducing the risk of contamination and preparation time. The prepared PRP can reduce the concentration of inflammatory factors represented by white blood cells, IL-1β and TNF-α, and improve the regeneration and repair effect of PRP.

[0055] Embodiment 2:

[0056] This embodiment is further optimized on the basis of the above embodiment, and further adopts the following configuration structure in order to better realize the present invention:

[0057] The PRP preparation device also includes a collecting funnel 5, and the centrifuge tube connection port 4 of the sterile protective cover 1 is sealed and connected to the collecting funnel 5. The sterile protective cover 1 can be directly sealed and connected to the discharge port of the collecting funnel 5 with the centrifuge tube connection port 4, or the collecting funnel 5 can be wrapped and sealed and connected to the discharge port of the collecting funnel 5, and the centrifuge tube connection port 4 is connected to the discharge end of the collecting funnel 5. The collecting funnel 5 is conducive to collecting the filtrate and can speed up the collection of the filtrate. A sterile cap is installed at the discharge end of the collecting funnel 5, and the discharge end of the collecting funnel 5 is used to connect the centrifuge tube 7. The height of the collecting funnel 5 is 1-2cm, such as 1cm, 1.2cm, 1.5cm and 2cm, and the volume of the collecting funnel 5 is generally 20-30ml, such as 20ml, 22ml, 25ml, 28ml, 30ml.

[0058] The PRP preparation device can also be pre-configured with a blood collection tube 6 and a centrifuge tube 7, the blood collection tube 6 is detachably connected to the blood collection tube connection port 3 of the sterile protective cover 1, and the centrifuge tube 7 is detachably connected to the discharge end of the collecting funnel 5. In order to facilitate blood collection, centrifugation and injection, the blood collection tube 6 is an injection needle structure with an injection piston, and the centrifuge tube 7 is an injection needle structure with an injection piston. The blood collection tube 6 and the centrifuge tube 7 with the injection piston can facilitate the filtration after blood collection and the centrifugation after obtaining the filtrate, reduce the intermediate operation time and improve the centrifugation efficiency.

[0059] Embodiment 3:

[0060] This embodiment provides a method for preparing PRP. The method for preparing PRP uses a blood collection tube, a centrifuge tube, a centrifuge, and the PRP preparation device in Example 2 to prepare PRP. It can obtain high-concentration PRP more quickly, reduce the risk of contamination and preparation time, reduce the total amount of blood drawn from patients, reduce blood waste, and solve the problem of filtering out red blood cells while avoiding red blood cells covering the filter membrane. The method for preparing PRP includes the following steps:

[0061] Step S1: Connect the centrifuge tube to the centrifuge tube connection port of the sterile protective cover.

[0062] After step S1 is completed, step S2 is performed: collecting the patient's own venous blood into a blood collection tube under sterile conditions, wherein the blood volume in the blood collection tube is controlled to be 20-30 ml.

[0063] After step S2 is completed, step S3 is performed: the sterile cap of the blood collection tube connection port is removed and the blood collection tube after collecting blood is connected to the blood collection tube connection port of the sterile protective cover. After connection, the injection piston of the blood collection tube is pushed to squeeze out the blood in the blood collection tube, and the squeezed blood falls to the filter membrane for filtration to obtain a filtrate. Meanwhile, the filtrate flows along the sterile protective cover or the collecting funnel to the front end of the needle tube of the centrifuge tube.

[0064] After step S3 is completed, step S4 is performed: the injection piston of the centrifuge tube is pulled to introduce the accumulated filtrate into the centrifuge tube, and then the seal of the centrifuge tube containing the filtrate is removed, and then the injection piston of the centrifuge tube is installed upward into the mounting bracket or sleeve of the centrifuge.

[0065] After step S4 is completed, proceed to step S5: cover the centrifuge cover and set the centrifugation time and centrifugal force. After the setting is completed, start the centrifuge. The centrifugation time of the centrifuge is set to 5-8 minutes, such as 5 minutes, 6 minutes, 7 minutes, and 8 minutes. The centrifugal force is set to 300-400×g, such as 300×g, 350×g, and 400×g.

[0066] After step S5 is completed, high-concentration PRP can be obtained, and the lower layer of PRP in the centrifuge tube can be injected into the patient's body.

[0067] This PRP preparation method can quickly and as much as possible separate plasma and platelets from blood by using the PRP preparation device in Example 2, and filter out as many white blood cells and red blood cells as possible, thereby quickly obtaining high-concentration PRP, reducing the risk of contamination and preparation time, and reducing the total amount of blood drawn from existing patients from 60ml to 20-30ml, thereby reducing blood waste and solving the problem of red blood cells and the like covering the filter membrane. The filter membrane 2 in the PRP preparation device is a non-charged polyester fiber non-woven fabric, which will not act on the growth factors with charges and reduce the amount of growth factors filtered. The filtration pore size of the filter membrane 2 is below 7μm, which can block most of the white blood cells while blocking the red blood cells, and can greatly reduce the number of white blood cells and red blood cells in the filtrate, and can obtain purer PPP (platelet-deficient plasma) and platelets. It can reduce the total amount of blood drawn from patients to reduce the generation of blood waste and effectively solve the problem of red blood cells covering the filter membrane and clogging the filter membrane. When the filtrate is centrifuged, a high concentration of PRP can be obtained more quickly, reducing the risk of contamination and preparation time. The prepared PRP can reduce the concentration of inflammatory factors represented by white blood cells, IL-1β and TNF-α, and improve the regeneration and repair effect of PRP.

[0068] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A PRP preparation device, characterized in that: It comprises a sterile protective cover (1) and a filter membrane (2); The inner side of the sterile protective cover (1) forms a storage space, and the sterile protective cover (1) is provided with a blood collection tube connection port (3) and a centrifuge tube connection port (4) which are communicated with the storage space, the blood collection tube connection port (3) is used to connect the blood collection tube, and the centrifuge tube connection port (4) is used to connect the centrifuge tube; The filter membrane (2) is arranged in the accommodation space of the sterile protective cover (1), the circumference of the filter membrane (2) is connected to the inner wall of the sterile protective cover (1), the filter membrane (2) is located between the blood collection tube connection port (3) and the centrifuge tube connection port (4), the filter membrane (2) comprises at least one layer of uncharged single-layer polyester fiber non-woven fabric, and the filter pore size of the filter membrane (2) is greater than or equal to 2 μm and less than or equal to 5 μm; The blood from the blood collection tube connection port (3) can be filtered through the filter membrane (2) and then flow through the centrifuge tube connection port (4); It also comprises a collecting funnel (5), the centrifuge tube connection port (4) of the sterile protective cover (1) is sealedly connected to the collecting funnel (5), and the centrifuge tube connection port (4) is in communication with the discharge end of the collecting funnel (5); It also includes a blood collection tube (6) and a centrifuge tube (7), wherein the blood collection tube (6) is detachably connected to the blood collection tube connection port (3) of the sterile protective cover (1), and the centrifuge tube (7) is detachably connected to the discharge end of the collecting funnel (5); The blood collection tube (6) is an injection needle structure with an injection piston, and the centrifuge tube (7) is an injection needle structure with an injection piston; A PRP preparation method using a blood collection tube, a centrifuge tube, a centrifuge and a PRP preparation device to prepare PRP comprises the following steps: S1. Connect the centrifuge tube to the centrifuge tube connection port of the sterile protective cover; S2. Collect the patient's own venous blood into a blood collection tube under sterile conditions; S3, connecting the blood collection tube after collecting blood to the blood collection tube connection port of the sterile protective cover, and squeezing the blood in the blood collection tube to the filter membrane for filtering to obtain a filtrate; S4, introducing the filtrate into a centrifuge tube, removing the seal of the centrifuge tube containing the filtrate and installing it in a centrifuge; S5, setting the centrifugal time and centrifugal force and starting the centrifuge; The centrifugation time of the centrifuge is set at 5-8 minutes and the centrifugal force is set at 350-400×g.

2. A PRP preparation device according to claim 1, characterized in that: The blood collection tube connection port (3) and the centrifuge tube connection port (4) of the sterile protective cover (1) are installed with sterile caps.

3. A PRP preparation device according to claim 1, characterized in that: The discharge end of the collecting funnel (5) is equipped with a sterile cap, and the discharge end of the collecting funnel (5) is used to connect a centrifuge tube.

4. A PRP preparation device according to claim 1, characterized in that: The sterile protective cover (1) is a sterile transparent plastic shell or a sterile transparent plastic film.

5. A PRP preparation device according to claim 1, characterized in that: The blood volume in the blood collection tube is controlled at 20-30 ml.